Savara Resubmits the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced today that it has resubmitted the MOLBREEVI BLA to the FDA, with ...
IEEE

Contribution to Human Respiratory System Modelling Using Electrical Networks

Abstract: This study presents a comprehensive model of the human respiratory system using electrical circuit analogies to explore its acoustic and mechanical characteristics. The model segments the ...